(Q37844488)

24 August 2017

1 reference

title

Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review (English)

1 reference

24 August 2017

0 references

1 reference

irritable bowel syndrome

1 reference

1

1 reference

24 August 2017

2

Nicholas J Talley

1 reference

24 August 2017

18 February 2011

1 reference

Journal of Gastroenterology

24 August 2017

1 reference

24 August 2017

46

1 reference

24 August 2017

421-431

1 reference

24 August 2017

4

1 reference

Functional bowel disorders

24 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Familial aggregation of irritable bowel syndrome: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: results 3 years after gastroenteritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Unbalanced expression of protease-activated receptors-1 and -2 in the colon of diarrhea-predominant irritable bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Role for protease activity in visceral pain in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Mucosal cytokine imbalance in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Empirical evidence of design-related bias in studies of diagnostic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Rifaximin therapy for patients with irritable bowel syndrome without constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Use of serum biomarkers in a diagnostic test for irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Dyspeptic symptoms and gastric emptying in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0379-9

Is the irritable gut an inflamed gut?

21 January 2018

1 reference

12 December 2020

Terminal ileal mucosal mast cells in irritable bowel syndrome

1 reference

12 December 2020

Activation of the mucosal immune system in irritable bowel syndrome

1 reference

12 December 2020

Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study

1 reference

12 December 2020

A pilot study of colonic B cell pattern in irritable bowel syndrome

1 reference

12 December 2020

Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time

1 reference

12 December 2020

Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome

1 reference

12 December 2020

Functional abdominal pain: further evidence that whole gut is affected.

1 reference

12 December 2020

Identifying dyspepsia and irritable bowel syndrome: the value of pain or discomfort, and bowel habit descriptors

1 reference

12 December 2020

Increased mast cells in the irritable bowel syndrome

1 reference

12 December 2020

10.1007/S00535-011-0379-9

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21331765